Back
GMN
Gold Mountain Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 23.50%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Gold Mountain Ltd. is an active junior gold explorer with portfolio of gold exploration projects situated in New South Wales, Australia. These assets are prospective for a range of metals including rare earth elements, niobium, lithium, nickel, copper and gold. The firm has a 75% holding in a package of highly prospective rare earth element, niobium, copper and lithium licenses located within the eastern Brazilian lithium belt, spread over parts of the Borborema Province and Sao Francisco craton in north-eastern Brazil, including in Salinas, Mines Gerais. In PNG, the Company is exploring the Wabag Project, which covers approximately 950 square kilometers (km2) of highly prospective exploration ground in the Papuan Mobile belt. This project includes three targets: Mt Wipi, Monoyal and Sak Creek, all lying within a northwest-southeast striking structural corridor. The company also has approximately 41 new tenement applications covering 803.5 km2 in the Maracas region of Bahia State (Ronaldinho REE Project).
📈 Performance
Price History
+50.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.09
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in GMN
7
📊 Total Capital Earnings
$7K
🔃 Average investment frequency
42 weeks
💵 Average investment amount
$720
⏰ Last time a customer invested in GMN
24 days
GMN investor breakdown
💵 Income of investors
More than 200k
150k - 200k
13%
100k - 150k
50k - 100k
13%
Less than 50k
75%
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
57%
Male
43%
Pearlers who invest in GMN also invest in...
🙌 Performance (5Yr p.a)
21.67%
📊 Share price
$0.10 AUD
📈 HIGH PRICE GROWTH
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
8.37%
📊 Share price
$111.98 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🧱 MATERIALS
Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.
🙌 Performance (5Yr p.a)
-4.67%
📊 Share price
$0.09 AUD
🩺 HEALTH CARE
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
17.59%
📊 Share price
$154.35 AUD
🤖 TECHNOLOGY
🌏 GLOBAL
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
Want more shares? Try these...
